Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6RKF

Structure of human DASPO

Summary for 6RKF
Entry DOI10.2210/pdb6rkf/pdb
DescriptorD-aspartate oxidase, FLAVIN-ADENINE DINUCLEOTIDE, GLYCEROL, ... (6 entities in total)
Functional Keywordsd-aspartate oxidase, d-aspartate, flavoprotein, oxidase, daspo, hdaspo, ddo, hddo oxidoreductase, fad
Biological sourceHomo sapiens (Human)
Total number of polymer chains6
Total formula weight238106.49
Authors
Chaves-Sanjuan, A.,Nardini, M. (deposition date: 2019-04-30, release date: 2020-03-11, Last modification date: 2024-01-24)
Primary citationMolla, G.,Chaves-Sanjuan, A.,Savinelli, A.,Nardini, M.,Pollegioni, L.
Structure and kinetic properties of human d-aspartate oxidase, the enzyme-controlling d-aspartate levels in brain.
Faseb J., 34:1182-1197, 2020
Cited by
PubMed Abstract: d-Amino acids are the "wrong" enantiomers of amino acids as they are not used in proteins synthesis but evolved in selected functions. On this side, d-aspartate (d-Asp) plays several significant roles in mammals, especially as an agonist of N-methyl-d-aspartate receptors (NMDAR), and is involved in relevant diseases, such as schizophrenia and Alzheimer's disease. In vivo modulation of d-Asp levels represents an intriguing task to cope with such pathological states. As little is known about d-Asp synthesis, the only option for modulating the levels is via degradation, which is due to the flavoenzyme d-aspartate oxidase (DASPO). Here we present the first three-dimensional structure of a DASPO enzyme (from human) which belongs to the d-amino acid oxidase family. Notably, human DASPO differs from human d-amino acid oxidase (attributed to d-serine degradation, the main coagonist of NMDAR) showing peculiar structural features (a specific active site charge distribution), oligomeric state and kinetic mechanism, and a higher FAD affinity and activity. These results provide useful insights into the structure-function relationships of human DASPO: modulating its activity represents now a feasible novel therapeutic target.
PubMed: 31914658
DOI: 10.1096/fj.201901703R
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.219 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon